Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18759641 | 0.83 | TSHR (0.31) | — | |
| SCHEMBL15299034 | 0.75 | TSHR (0.37) | — | |
| SCHEMBL26104346 | 0.74 | — | — | |
| SCHEMBL4889273 | 0.73 | TSHR (0.31) | — | |
| SCHEMBL26101396 | 0.73 | TSHR (0.34) | — | |
| Ammonia Solution, Strong SCHEMBL1962259 | 0.73 | TSHR (0.35) | — | |
| SCHEMBL28100341 | 0.72 | FDPS (0.32) | FDPS | |
| SCHEMBL28414261 | 0.71 | FDPS (0.35) | FDPS | |
| SCHEMBL18759591 | 0.70 | TSHR (0.35) | — | |
| SCHEMBL4894179 | 0.69 | TSHR (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080293880-A1 | Liquid, Thermally Curable Mixtures, Their Preparation and Use | BASF COATINGS AG (DE) | 2008-11-27 | — | — | US | claimed |
| EP-2358778-B1 | METHOD FOR PREPARING AN ALLOPHANATE, ALLOPHANATE, AND LOW-VISCOSITY COMPOSITION CONTAINING THE ALLOPHANATE | VENCOREX FRANCE (FR) | 2018-11-28 | — | — | EP | disclosed |
| CN-102317335-B | Process for preparing allophanates, allophanates and low-viscosity compositions containing them | VENCOREX FRANCE (FR) | 2014-10-29 | — | — | CN | disclosed |
| US-8716426-B2 | Method for preparing an allophanate, allophanate, and low-viscosity composition containing the allophanate | PERSTORP FRANCE (FR) | 2014-05-06 | — | — | US | disclosed |
| US-20120016073-A1 | METHOD FOR PREPARING AN ALLOPHANATE, ALLOPHANATE, AND LOW-VISCOSITY COMPOSITION CONTAINING THE ALLOPHANATE | PERSTORP FRANCE (FR) | 2012-01-19 | — | — | US | disclosed |
| CN-102317335-A | Process for preparing allophanates, allophanates and low-viscosity compositions containing them | PERSTORP FRANCE | 2012-01-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016073-A1 | METHOD FOR PREPARING AN ALLOPHANATE, ALLOPHANATE, AND LOW-VISCOSITY COMPOSITION CONTAINING THE ALLOPHANATE | FHIT, DOHH, MTDH | FDPS 672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.